Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

1(33.3%)

Phase 3

1(33.3%)

Phase 4

1(33.3%)

3Total

N/A(1)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT02861612Withdrawn

Nerve Transfers to Restore Hand Function in Spinal Cord Injury

Role: collaborator

NCT01398982Phase 4Completed

TAP Block in DIEP or Free MS-TRAM Donor Site: A RCT

Role: collaborator

NCT00565019Phase 3Completed

Effects of Steroid Injection With Percutaneous Needle Aponeurotomy in Dupuytren's Contracture

Role: collaborator

NCT00149344Not ApplicableCompleted

Vertical Scar Versus Inferior Pedicle Reduction Mammoplasty

Role: collaborator

All 4 trials loaded